Superbugs & Superdrugs USA Conference returns to New Jersey this November
Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group is pleased to announce the release of the official agenda for the 3rd annual Superbugs & Superdrugs USA Conference, which is due to take place in Iselin, New Jersey on November 12 - 13, 2018.
Antimicrobial resistance, leading to the development of superbugs, is a major threat to public health and continues to increase as a problem, due to continued misuse of antibiotics. With pharmaceutical companies showing less focus on the development of new antibiotics, several incentive initiatives have been set up - CARBX, BARDA, IMI (EU) - in order to encourage reinvestments. From a governmental point of view, the challenge lies in encouraging companies to develop new antimicrobial drugs and to strengthen and maintain the pipeline of antibiotics and other antimicrobials currently being developed.
This years' Superbugs & Superdrugs USA Conference programme will help participants to learn about pathogen focused drug development; discover the best methods to overcome bacterial resistance through novel modes of action; discuss the state of developments within the antifungal space; develop an understanding of funding opportunities which support antibacterial research and development; gain insight into new techniques through case-study examples of rapid diagnostic methods currently being used within the field, making this event the perfect platform to strengthen knowledge in key principles.
• Anthony Simon Lynch, Senior Scientific Director, Janssen
• William Weiss, Director, Pre-Clinical Services, UNT Health Science Center
• Tina Guina, Program Officer, Drug Development Section, NIAID/NIH
• Mark Albrecht, Project Officer, HHS/ASPR/BARDA
• Antonio DiGiandomenico, Principal Scientist, MedImmune
• Andrew Tomaras, VP & Director of Microbiology, Bacterioscan
• Dan Pevear, Sr Vice President & Director of Microbiology, VenatoRx
• Ian Friedland, Clinical Consultant, ex-CMO, Achaogen
Plus, topical workshops on November 14:
• Rapid diagnostics for drug resistance: Are we there yet?
• Avoiding the post antibiotic era: the challenges and solutions to successful commercialisation of new antibiotics
Further details at http://www.superbugs-usa.com/openpr
Twitter - @SMIpharm & #smibugs
LinkedIn - SMi Pharma
+44 (0)20 7827 6000
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
SMi Group Ltd
1 Westminster Bridge Rd, South Bank, London SE1 7XW
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Superbugs & Superdrugs USA Conference returns to New Jersey this November here
News-ID: 1074032 • Views: 415
More Releases from SMi Group
Mr Andy Palmer, Border Security Manager at Gatwick Airport to present at the 14t …
SMi Group Reports: Mr Andy Palmer from Gatwick Airport is a new speaker for the virtual Border Security conference next February Interested parties must secure their place soon at the most focused Border Security conference in Europe, taking place virtually on 10th and 11th February 2021. Now running for 14 years, SMi Group’s Border Security conference has established itself as one of the leading conferences that provide delegates with a platform
Just Two Weeks To Go Until the 2020 Energy from Waste Conference
Energy from Waste 2020 will bring together international waste management operators, developers, bankers, private equity financiers, technology providers and industrial end users to explore updates in EfW technology, financing and infrastructure, with the goal to ensure the solutions are available to fast track the growth of the industry worldwide. Taking place as a virtual event on the 1st – 2nd December, the conference will enable the Energy from Waste community to
Invitation released from Conference Chair Laurent Donnet, Avidonn Consulting for …
SMi Group Reports: The conference chair invites the military airlift and AAR community to attend the Military Airlift and Air-to-Air Refuelling virtual conference next month. With just 3 weeks to go, there is still time to register for the highly anticipated, 21st annual Military Airlift and Air-to-Air Refuelling conference taking place virtually on the 1st and 2nd December 2020. All attendance by military and government personnel will be free of charge and
An industry Outlook: latest regulatory challenges in Pre-filled syringe innovati …
SMi Reports: speaker session with Bjørg Kaae Hunter, Department Manager, RA CMC & Device, Novo Nordisk at Pre-filled Syringes and Injectable Drug Devices Conference 2021. Now in its 13th year, we have witnessed significant growth and innovation in the pre-filled syringe and injection device market as well as in the regulatory landscape. Bjørg Kaae Hunter, Department Manager, RA CMC & Device+; RA NextGen Drug-Device, Novo Nordisk will be discussing: An industry Outlook:
More Releases for Superbugs
Interview with Martin Everett speaker at SMi's Superbugs & Superdrugs Conference
SMi Reports: An Interview with Martin Everett, Chief Scientific Officer, at Antabio, who will be speaking at SMi's highly anticipated 22nd Annual Superbugs & Superdrugs Conference on the 30th and 31st March 2020 in London. This year's global focused two-day conference pharmaceutical is for industry professionals looking to gain an in-depth knowledge of the scientific, economic, and regulatory challenges facing the critical global issue of antibiotic resistance. For interested individuals to attend
Four weeks until SMi’s 21st Annual Superbugs & Superdrugs Conference 2019
SMi Reports: Senior industry experts will gather in London to discuss the recent advances made in combating antibiotic resistance. As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. For this reason, the Superbugs & Superdrugs conference, taking
Registration Officially Opens for the 21st Annual Superbugs & Superdrugs Confere …
As the global threat of antimicrobial resistance continues to grow, the advances of modern medicine are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. SMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London, UK for its 21st year running, on the 18th & 19th March 2019 (http://www.superbugssuperdrugs.com/openpr). This
W. J. Wiess and A.S. Lynch invitation to SMi’s Superbugs & Superdrugs USA Conf …
SMi Group reports: William J. Weiss - University of North Texas Health Science Center and Anthony Simon Lynch - Janssen supporting SMi's Superbugs & Superdrugs USA Conference, which is due to take place this November in New Jersey William and Anthony are chairing SMi's Superbugs & Superdrugs USA Conference and encourage all involved in AMR to join experts from multiple disciplines, in the field of infectious disease representing research, regulatory, funding,
Antibiotic Drug Experts + Senior Industry Leaders set to Gather at Superbugs USA
SMi Group will open doors in 3 weeks to host the next annual USA Superbugs summit when it returns to Iselin, New Jersey on Nov 13th – 14th. http://www.superbugs-usa.com/opr Following over two decades of expertise in Europe, the USA show will gather senior industry experts to delve deeper into core issues surrounding government funding and initiatives, breakthroughs in drug discovery, strategies to strengthen the antibiotic pipeline and resistance prevention. Highlights will include
Motif Biosciences Unveil Novel Solutions for the Treatment Deadly Superbugs
SMi Group will welcome the expertise of David Huang when he presents exclusive updates on Iclaprim, a novel diaminopyrimidine, for the treatment of serious gram- positive infections, at Superbugs & Superdrugs USA this fall. The talk will explore how Iclaprim addresses an unmet medical need in hospitalized patients with serious and life-threatening infections including MRSA. With over 15 years of clinical, academic, industry, and research experience in medicine and in the